# Contact Tesa Compound: Editorial Inquiries on the Tesamorelin Record

> Contact Tesa Compound with editorial inquiries, corrections, or source suggestions on the tesamorelin research digest. We do not provide medical advice and we do not sell any product.

Editorial inquiries, corrections, and source suggestions on the tesamorelin research record.

## Editorial inquiries only

Use the form below for editorial matters: corrections, source suggestions, or questions about how a claim on this tesamorelin digest is sourced. If you believe a figure is misattributed or a citation is broken, tell us which page and which reference number, and we will check it against the source.

We cannot answer medical questions. We are not a clinic, we do not employ clinicians, and we do not provide medical, dosing, or treatment advice. Questions about whether tesamorelin is appropriate for a person belong with a qualified healthcare professional, not with an editorial publisher. We also do not sell, supply, or source tesamorelin, and we cannot help with obtaining it.

## What to expect

This is a small editorial project, so responses are not instantaneous. Messages that identify a specific, verifiable issue — a wrong number, a dead link, a study we missed — get priority, because keeping the record accurate is the entire point of the site. General questions about tesamorelin are better answered by the research and FAQ pages, which are written to be read directly and are cited throughout.

We do not collect more than the message you send. Nothing on this site is a transaction, and there is no product, account, or order behind this form.

---

The tesamorelin literature read as a validated record — every figure typed to its field and carried back to its study, the FDA scope (HIV-associated lipodystrophy only), the labeled contraindications, and the off-label edge surfaced as the record's leading status; a digest that flags before it reports, never a clinic, a vendor, or a prescription.